The Propanc Biopharma (PPCB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 554,900.00%, with a year-to-date return of 1,109,900.00%. In the past month, the stock has decreased 64.23%, reflecting recent market activity.
As of the latest close, Propanc Biopharma traded at $1.98 with a market cap of $22.99 million and volume of 390,695 shares. Five years ago, the stock traded at a split-adjusted price of $1.80, representing a 23.33% increase over that period. At the time, it had a market cap of $1.20 million and a volume of 3,290 shares.